APOTEEK RIGAUX: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
APOTEEK RIGAUX
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€3,020
2024 · -€16,597+€19,617
Equity
€320,007
2024 · €316,987+€3,020
Cash
€49,681
2024 · €75,083-€25,402
Balance sheet total
€1.2m
2024 · €1.3m-€83,529
Largest movements
Assets
- Tangible fixed assets -€74,228
down €74,228 (-8.2%), from €910,216 to €835,988
of which Land and buildings: -€44,323
- Cash -€25,402
down €25,402 (-33.8%), from €75,083 to €49,681
mainly Debts after one year (-€64,770) and Trade debts (-€11,533)
Equity and liabilities
- Debts after one year -€64,770
down €64,770 (-19.9%), from €324,976 to €260,206
Income statement
- Staff costs -€14,258
down €14,258 (-21.8%), from €65,341 to €51,084
- Depreciation -€3,535
down €3,535 (-4.1%), from €86,365 to €82,830
- Gross operating margin +€1,714
up €1,714 (+1.1%), from €151,261 to €152,976
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
-€16,597
Gross operating margin
+€1,714
Staff costs
+€14,258
Depreciation
+€3,535
Other operating charges
-€845
Financial income
-€77
Financial charges
+€1,028
Taxes
+€4
Result 2025
€3,020
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€46,531
Investment
-€8,602
Financing
-€63,331
Cash 2024
€75,083
From operations (derived)
+€46,531
Net result for the year
+€3,020
Depreciation
+€82,830
Stocks and contracts
-€10,901
Receivables within one year
-€3,223
Deferred charges and accrued income
-€1,978
Trade debts
-€11,533
Tax, wage and social debts
-€4,283
Other debts
-€7,402
Investment (derived)
-€8,602
Investment in fixed assets (net)
-€8,602
Financing
-€63,331
Debts after one year
-€64,770
Current portion of long-term debt
+€1,438
Cash 2025
€49,681
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,329,012 | €1,245,483 | -€83,529 | -6.3% |
| Fixed assets | 21/28 | €910,216 | €835,988 | -€74,228 | -8.2% |
| Tangible fixed assets | 22/27 | €910,216 | €835,988 | -€74,228 | -8.2% |
| Land and buildings | 22 | €861,288 | €816,965 | -€44,323 | -5.1% |
| Plant, machinery and equipment | 23 | €48,637 | €19,023 | -€29,614 | -60.9% |
| Furniture and vehicles | 24 | €291 | €0 | -€291 | -100% |
| Current assets | 29/58 | €418,795 | €409,495 | -€9,301 | -2.2% |
| Stocks and contracts in progress | 3 | €222,923 | €233,824 | +€10,901 | +4.9% |
| Stocks | 30/36 | €222,923 | €233,824 | +€10,901 | +4.9% |
| Amounts receivable within one year | 40/41 | €100,066 | €103,288 | +€3,223 | +3.2% |
| Trade receivables | 40 | €97,242 | €100,502 | +€3,260 | +3.4% |
| Other amounts receivable | 41 | €2,823 | €2,786 | -€37 | -1.3% |
| Cash at bank and in hand | 54/58 | €75,083 | €49,681 | -€25,402 | -33.8% |
| Deferred charges and accrued income | 490/1 | €20,724 | €22,701 | +€1,978 | +9.5% |
| Total equity and liabilities | 10/49 | €1,329,012 | €1,245,483 | -€83,529 | -6.3% |
| Equity | 10/15 | €316,987 | €320,007 | +€3,020 | +1.0% |
| Contributions | 10/11 | €150,000 | €150,000 | = | 0.0% |
| Reserves | 13 | €213,352 | €213,352 | = | 0.0% |
| Non-distributable reserves | 130/1 | €15,000 | €15,000 | = | 0.0% |
| Reserves not available under the articles | 1311 | €15,000 | €15,000 | = | 0.0% |
| Distributable reserves | 133 | €198,352 | €198,352 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€46,365 | -€43,345 | +€3,020 | +6.5% |
| Amounts payable | 17/49 | €1,012,025 | €925,477 | -€86,548 | -8.6% |
| Amounts payable after more than one year | 17 | €324,976 | €260,206 | -€64,770 | -19.9% |
| Financial debts | 170/4 | €324,976 | €260,206 | -€64,770 | -19.9% |
| Amounts payable within one year | 42/48 | €687,049 | €665,271 | -€21,779 | -3.2% |
| Current portion of amounts payable after more than one year | 42 | €64,978 | €66,417 | +€1,438 | +2.2% |
| Trade debts | 44 | €75,569 | €64,036 | -€11,533 | -15.3% |
| Suppliers | 440/4 | €75,569 | €64,036 | -€11,533 | -15.3% |
| Taxes, remuneration and social security | 45 | €15,499 | €11,216 | -€4,283 | -27.6% |
| Taxes | 450/3 | €2,614 | €1,600 | -€1,014 | -38.8% |
| Remuneration and social security | 454/9 | €12,885 | €9,616 | -€3,268 | -25.4% |
| Other amounts payable | 47/48 | €531,003 | €523,601 | -€7,402 | -1.4% |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Remuneration, social security and pensions | 62 | €65,341 | €51,084 | -€14,258 | -21.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €86,365 | €82,830 | -€3,535 | -4.1% |
| Other operating charges | 640/8 | €882 | €1,727 | +€845 | +95.7% |
| Gross operating margin | 9900 | €151,261 | €152,976 | +€1,714 | +1.1% |
| Operating profit (loss) | 9901 | -€1,327 | €17,335 | +€18,662 | |
| Financial income | 75/76B | €121 | €44 | -€77 | -63.8% |
| Recurring financial income | 75 | €121 | €44 | -€77 | -63.8% |
| Financial charges | 65/66B | €15,331 | €14,303 | -€1,028 | -6.7% |
| Recurring financial charges | 65 | €15,331 | €14,303 | -€1,028 | -6.7% |
| Profit (loss) for the period before taxes | 9903 | -€16,537 | €3,076 | +€19,613 | |
| Income taxes | 67/77 | €61 | €57 | -€4 | -6.7% |
| Profit (loss) for the period | 9904 | -€16,597 | €3,020 | +€19,617 | |
| Profit (loss) for the period to be appropriated | 9905 | -€16,597 | €3,020 | +€19,617 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.